Literature DB >> 19496923

A +220 GATA motif mediates basal but not endotoxin-repressible expression of the von Willebrand factor promoter in Hprt-targeted transgenic mice.

J Liu1, Y Kanki, Y Okada, E Jin, K Yano, S-C Shih, T Minami, W C Aird.   

Abstract

BACKGROUND: The von Willebrand factor (VWF) gene is a marker for spatial and temporal heterogeneity of the endothelium. A GATA motif at +220 has been implicated in basal VWF expression in vitro. Other studies have shown that GATA3 and VWF are transcriptionally downregulated in response to inflammatory mediators.
OBJECTIVES: Our goal was to determine the importance of the +220 GATA motif in mediating expression of VWF promoter in vivo, and to elucidate whether the GATA element plays a role in spatial and/or temporal regulation of VWF expression.
METHODS: ChIP and electrophoretic mobility shift assays were carried out in human umbilical vein endothelial cells (HUVEC). Reporter gene constructs containing 3.6 kb of the human VWF promoter with and without a mutation of the +220 GATA element were transfected into cultured endothelial cells or targeted to the Hprt locus of mice. The Hprt-targeted mice were subjected to endotoxemia.
RESULTS: In protein-DNA binding assays, the +220 GATA motif bound GATA-2, -3 and -6. Mutation of the GATA site resulted in reduced basal promoter activity in HUVEC. When targeted to the Hprt locus of mice, the GATA mutation resulted in a significant, proportionate reduction of promoter activity in LacZ expressing vascular beds. Systemic administration of lipopolysaccharide (LPS) resulted in a widespread reduction in VWF mRNA expression and promoter activity. LPS-mediated repression of the VWF promoter was unaffected by the GATA mutation.
CONCLUSIONS: A region of the VWF promoter between -2182 and the end of the first intron contains information for LPS-mediated gene repression. The +220 GATA motif is important for basal, but not LPS-repressible expression of the VWF gene.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19496923      PMCID: PMC5303625          DOI: 10.1111/j.1538-7836.2009.03501.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  34 in total

Review 1.  Endothelial cell heterogeneity.

Authors:  William C Aird
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

2.  Transforming growth factor-beta 1-mediated inhibition of the flk-1/KDR gene is mediated by a 5'-untranslated region palindromic GATA site.

Authors:  T Minami; R D Rosenberg; W C Aird
Journal:  J Biol Chem       Date:  2000-11-29       Impact factor: 5.157

3.  Variation at the von Willebrand factor (vWF) gene locus is associated with plasma vWF:Ag levels: identification of three novel single nucleotide polymorphisms in the vWF gene promoter.

Authors:  A M Keightley; Y M Lam; J N Brady; C L Cameron; D Lillicrap
Journal:  Blood       Date:  1999-06-15       Impact factor: 22.113

4.  A single nucleotide polymorphism at nucleotide -1793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF:Ag levels.

Authors:  P J Harvey; A M Keightley; Y M Lam; C Cameron; D Lillicrap
Journal:  Br J Haematol       Date:  2000-05       Impact factor: 6.998

5.  Targeting the Hprt locus in mice reveals differential regulation of Tie2 gene expression in the endothelium.

Authors:  V Evans; A Hatzopoulos; W C Aird; H B Rayburn; R D Rosenberg; J A Kuivenhoven
Journal:  Physiol Genomics       Date:  2000-03-13       Impact factor: 3.107

6.  Cell type-specific regulation of von Willebrand factor expression by the E4BP4 transcriptional repressor.

Authors:  Christine Hough; Carla D Cuthbert; Colleen Notley; Christine Brown; Carol Hegadorn; Ergul Berber; David Lillicrap
Journal:  Blood       Date:  2004-10-21       Impact factor: 22.113

7.  Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis.

Authors:  Takashi Minami; Keiko Horiuchi; Mai Miura; Md Ruhul Abid; Wakako Takabe; Noriko Noguchi; Takahide Kohro; Xijin Ge; Hiroyuki Aburatani; Takao Hamakubo; Tatsuhiko Kodama; William C Aird
Journal:  J Biol Chem       Date:  2004-09-23       Impact factor: 5.157

8.  A three-kilobase fragment of the human Robo4 promoter directs cell type-specific expression in endothelium.

Authors:  Yoshiaki Okada; Kiichiro Yano; Enjing Jin; Nobuaki Funahashi; Mie Kitayama; Takefumi Doi; Katherine Spokes; David L Beeler; Shu-Ching Shih; Hitomi Okada; Tatyana A Danilov; Elizabeth Maynard; Takashi Minami; Peter Oettgen; William C Aird
Journal:  Circ Res       Date:  2007-05-10       Impact factor: 17.367

9.  A GABP-binding element in the Robo4 promoter is necessary for endothelial expression in vivo.

Authors:  Yoshiaki Okada; Enjing Jin; Vesna Nikolova-Krstevski; Kiichiro Yano; Ju Liu; David Beeler; Katherine Spokes; Mie Kitayama; Nobuaki Funahashi; Takefumi Doi; Lauren Janes; Takashi Minami; Peter Oettgen; William C Aird
Journal:  Blood       Date:  2008-06-02       Impact factor: 22.113

10.  Single-copy transgenic mice with chosen-site integration.

Authors:  S K Bronson; E G Plaehn; K D Kluckman; J R Hagaman; N Maeda; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

View more
  17 in total

1.  Epigenetically coordinated GATA2 binding is necessary for endothelium-specific endomucin expression.

Authors:  Yasuharu Kanki; Takahide Kohro; Shuying Jiang; Shuichi Tsutsumi; Imari Mimura; Jun-Ichi Suehiro; Youichiro Wada; Yoshihiro Ohta; Sigeo Ihara; Hiroko Iwanari; Makoto Naito; Takao Hamakubo; Hiroyuki Aburatani; Tatsuhiko Kodama; Takashi Minami
Journal:  EMBO J       Date:  2011-06-10       Impact factor: 11.598

2.  Vascular bed-specific regulation of the von Willebrand factor promoter in the heart and skeletal muscle.

Authors:  Ju Liu; Lei Yuan; Grietje Molema; Erzsébet Regan; Lauren Janes; David Beeler; Katherine C Spokes; Yoshiaki Okada; Takashi Minami; Peter Oettgen; William C Aird
Journal:  Blood       Date:  2010-10-27       Impact factor: 22.113

3.  Functional characterization of a 13-bp deletion (c.-1522_-1510del13) in the promoter of the von Willebrand factor gene in type 1 von Willebrand disease.

Authors:  Maha Othman; Yvette Chirinian; Christine Brown; Colleen Notley; Nicholas Hickson; Daniel Hampshire; Suzanne Buckley; Simon Waddington; Alan L Parker; Andrew Baker; Paula James; David Lillicrap
Journal:  Blood       Date:  2010-08-09       Impact factor: 22.113

4.  Single-cell transcriptional analysis of human endothelial colony-forming cells from patients with low VWF levels.

Authors:  Christopher J Ng; Alice Liu; Sujatha Venkataraman; Katrina J Ashworth; Christopher D Baker; Rebecca O'Rourke; Rajeev Vibhakar; Kenneth L Jones; Jorge Di Paola
Journal:  Blood       Date:  2022-04-07       Impact factor: 22.113

5.  Hyperglycemia-induced oxidative stress promotes tumor metastasis by upregulating vWF expression in endothelial cells through the transcription factor GATA1.

Authors:  Han-Seok Jeong; Da-Hye Lee; Seung-Hoon Kim; Chang-Han Lee; Hyun Mu Shin; Hang-Rae Kim; Chung-Hyun Cho
Journal:  Oncogene       Date:  2022-01-29       Impact factor: 8.756

6.  Vascular endothelial growth factor activation of endothelial cells is mediated by early growth response-3.

Authors:  Jun-ichi Suehiro; Takao Hamakubo; Tatsuhiko Kodama; William C Aird; Takashi Minami
Journal:  Blood       Date:  2009-11-23       Impact factor: 22.113

7.  Role of RNA splicing in mediating lineage-specific expression of the von Willebrand factor gene in the endothelium.

Authors:  Lei Yuan; Lauren Janes; David Beeler; Katherine C Spokes; Joshua Smith; Dan Li; Shou-Ching Jaminet; Peter Oettgen; William C Aird
Journal:  Blood       Date:  2013-03-25       Impact factor: 22.113

Review 8.  Regulation of VWF expression, and secretion in health and disease.

Authors:  Yaozu Xiang; John Hwa
Journal:  Curr Opin Hematol       Date:  2016-05       Impact factor: 3.284

Review 9.  Inflammation, von Willebrand factor, and ADAMTS13.

Authors:  Junmei Chen; Dominic W Chung
Journal:  Blood       Date:  2018-06-04       Impact factor: 25.476

10.  Plasma von Willebrand factor level is transiently elevated in a rat model of acute myocardial infarction.

Authors:  Yan Li; Liqun Li; Fengyun Dong; Ling Guo; Yinglong Hou; Hesheng Hu; Suhua Yan; Xiaojun Zhou; Lin Liao; Thaddeus D Allen; J U Liu
Journal:  Exp Ther Med       Date:  2015-09-01       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.